National Research Corporation
General ticker "NRC" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $444.7M
National Research Corporation does not follow the US Stock Market performance with the rate: -33.3%.
Estimated limits based on current volatility of 2.9%: low 16.76$, high 17.76$
Factors to consider:
- Company pays dividends: last record date 2024-09-27, amount 0.12$ (Y2.69%)
- US accounted for 100.0% of revenue in the fiscal year ended 2023-12-31
- Current price 43.3% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [31.48$, 48.79$]
- 2024-12-30 to 2025-12-30 estimated range: [30.70$, 48.35$]
Financial Metrics affecting the NRC estimates:
- Positive: 0.93 < Non-GAAP EPS, $ of 1.25
- Positive: Operating profit margin, % of 26.95 > 19.51
- Positive: Return on assets ratio (scaled to [-100,100]) of 20.19 > 7.10
- Positive: -0.96 < Investing cash flow per share, $ of -0.64
- Positive: 3.85 < Industry operating cash flow per share per price (median), % of 5.45
- Positive: 2.35 < Operating cash flow per share per price, % of 3.81
Short-term NRC quotes
Long-term NRC plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $147.95MM | $151.57MM | $148.58MM |
| Operating Expenses | $97.68MM | $105.03MM | $108.53MM |
| Operating Income | $50.27MM | $46.54MM | $40.05MM |
| Non-Operating Income | $-1.65MM | $-3.73MM | $-0.08MM |
| Interest Expense | $1.67MM | $1.21MM | $0.86MM |
| Income(Loss) | $48.62MM | $42.81MM | $39.96MM |
| Taxes | $11.15MM | $11.02MM | $8.99MM |
| Profit(Loss) | $37.47MM | $31.80MM | $30.97MM |
| Stockholders Equity | $85.34MM | $72.03MM | $48.95MM |
| Inventory | $0.00MM | $0.00MM | $0.00MM |
| Assets | $157.54MM | $130.46MM | $122.44MM |
| Operating Cash Flow | $46.34MM | $36.27MM | $38.11MM |
| Capital expenditure | $5.51MM | $9.84MM | $15.78MM |
| Investing Cash Flow | $-8.51MM | $-9.84MM | $-15.78MM |
| Financing Cash Flow | $-18.16MM | $-55.58MM | $-40.71MM |
| Earnings Per Share* | $1.47 | $1.28 | $1.26 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.